KTTA Pasithea Therapeutics shares climb 21 percent despite reporting a far wider than expected Q4 2025 per share loss Why Fidelity D FDBC might surprise investors this quarter Grinds Higher 20260508 3 E MASK Stock Relative Valuation Review Ellington EFCC preferred stock maintains steady 8625 dividend drawing incomefocused investors seeking reliable returns